KP Tissue (TSE:KPT – Get Free Report) had its price target cut by equities research analysts at TD from C$14.00 to C$13.00 in a research note issued to investors on Wednesday, BayStreet reports. The firm currently has a “hold” rating on the stock. TD’s price objective suggests a potential upside of 11.97% from the stock’s previous close.
KP Tissue Trading Down 0.8%
Shares of KPT traded down C$0.09 on Wednesday, reaching C$11.61. 33,058 shares of the company’s stock were exchanged, compared to its average volume of 15,450. The business has a 50 day moving average price of C$12.57 and a two-hundred day moving average price of C$12.34. KP Tissue has a 12 month low of C$9.21 and a 12 month high of C$13.78. The stock has a market capitalization of C$116.47 million, a P/E ratio of 13.19, a price-to-earnings-growth ratio of -0.88 and a beta of 0.54.
KP Tissue (TSE:KPT – Get Free Report) last announced its quarterly earnings results on Thursday, August 13th. The company reported C$0.24 EPS for the quarter. Equities research analysts predict that KP Tissue will post 0.44 EPS for the current year.
About KP Tissue
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Featured Articles
- Five stocks we like better than KP Tissue
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with MarketBeat.com's FREE daily email newsletter.
